Revolutionary drug for schizophrenia wins US approvalKarXT represents a groundbreaking schizophrenia treatment with a unique mechanism of action that may improve patient outcomes and tolerability compared to existing therapies.
F.D.A. Approves the First New Schizophrenia Drug in DecadesCobenfy is the first new antipsychotic in decades, aiming to treat schizophrenia without severe side effects like weight gain.
Revolutionary drug for schizophrenia wins US approvalKarXT represents a groundbreaking schizophrenia treatment with a unique mechanism of action that may improve patient outcomes and tolerability compared to existing therapies.
F.D.A. Approves the First New Schizophrenia Drug in DecadesCobenfy is the first new antipsychotic in decades, aiming to treat schizophrenia without severe side effects like weight gain.